Through neonatal thymectomy and injection of anti-CD4 and -CD8α monoclonal antibodies, Morimura et al. found that depletion of chicken CD4 and CD8 T cells did not increase either tumor incidence or lesion, there was also no significant decrease in the survival rate of CVI988-vaccinated and challenged chickens. Here, CD8A is linked to neoplasm.